webinar register page

Jefferies & Eun Yang Host: Fireside Chat with BridgeBio (BBIO) Management Team
Please join us for the fireside chat with BBIO management team to discuss multiple topics on its acoramidis program, including data expectations for acoramidis Phase 3 in transthyretin amyloid cardiomyopathy (ATTR-CM), regulatory filing and commercialization strategy, competitive landscape, and market opportunity in ATTR-CM. BBIO’s Phase 3 for acoramidis in ATTR-CM is currently ongoing with Part A (12-month) data in December 2021 and Part B (30-month) data in 2023. The audience is welcome to submit questions beforehand by emailing Eun Yang eyang@jefferies.com or during the fireside chat.

Oct 19, 2021 01:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Valerie Kraus.